» Articles » PMID: 17289807

The Flatiron Mutation in Mouse Ferroportin Acts As a Dominant Negative to Cause Ferroportin Disease

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2007 Feb 10
PMID 17289807
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroportin disease is caused by mutation of one allele of the iron exporter ferroportin (Fpn/IREG1/Slc40a1/MTP1). All reported human mutations are missense mutations and heterozygous null mutations in mouse Fpn do not recapitulate the human disease. Here we describe the flatiron (ffe) mouse with a missense mutation (H32R) in Fpn that affects its localization and iron export activity. Similar to human patients with classic ferroportin disease, heterozygous ffe/+ mice present with iron loading of Kupffer cells, high serum ferritin, and low transferrin saturation. In macrophages isolated from ffe/+ heterozygous mice and through the use of Fpn plasmids with the ffe mutation, we show that Fpn(ffe) acts as a dominant negative, preventing wild-type Fpn from localizing on the cell surface and transporting iron. These results demonstrate that mutations in Fpn resulting in protein mislocalization act in a dominant-negative fashion to cause disease, and the Fpn(ffe) mouse represents the first mouse model of ferroportin disease.

Citing Articles

Minimizing higher-order aggregation maximizes iron mobilization by small molecules.

Blake A, Chao J, SantaMaria A, Ekaputri S, Green K, Brown S Nat Chem Biol. 2024; 20(10):1282-1293.

PMID: 38664586 PMC: 11831690. DOI: 10.1038/s41589-024-01596-3.


Effect of Picture-based health education and counselling on knowledge and adherence to preconception Iron-folic acid supplementation among women planning to be pregnant in Eastern Ethiopia: a randomized controlled trial.

Berhane A, Belachew T J Nutr Sci. 2022; 11:e58.

PMID: 35912303 PMC: 9305079. DOI: 10.1017/jns.2022.51.


A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages.

Ekaputri S, Choi E, Sabelli M, Aring L, Green K, Chang J Proc Natl Acad Sci U S A. 2022; 119(26):e2121400119.

PMID: 35737834 PMC: 9245668. DOI: 10.1073/pnas.2121400119.


Micronutrient imbalance and common phenotypes in neural tube defects.

Kakebeen A, Niswander L Genesis. 2021; 59(11):e23455.

PMID: 34665506 PMC: 8599664. DOI: 10.1002/dvg.23455.


Ironing Out the Details: How Iron Orchestrates Macrophage Polarization.

Xia Y, Li Y, Wu X, Zhang Q, Chen S, Ma X Front Immunol. 2021; 12:669566.

PMID: 34054839 PMC: 8149954. DOI: 10.3389/fimmu.2021.669566.


References
1.
Liu X, Yang F, Haile D . Functional consequences of ferroportin 1 mutations. Blood Cells Mol Dis. 2005; 35(1):33-46. DOI: 10.1016/j.bcmd.2005.04.005. View

2.
De Domenico I, Ward D, Nemeth E, Vaughn M, Musci G, Ganz T . The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci U S A. 2005; 102(25):8955-60. PMC: 1157058. DOI: 10.1073/pnas.0503804102. View

3.
Zoller H, McFarlane I, Theurl I, Stadlmann S, Nemeth E, Oxley D . Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Hepatology. 2005; 42(2):466-72. DOI: 10.1002/hep.20775. View

4.
Donovan A, Lima C, Pinkus J, Pinkus G, Zon L, Robine S . The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005; 1(3):191-200. DOI: 10.1016/j.cmet.2005.01.003. View

5.
Zohn I, Anderson K, Niswander L . Using genomewide mutagenesis screens to identify the genes required for neural tube closure in the mouse. Birth Defects Res A Clin Mol Teratol. 2005; 73(9):583-90. DOI: 10.1002/bdra.20164. View